Key result
Surgical Pleth Index guidance fails to reduce intraoperative remifentanil consumption compared to standard monitoring.
Why the study?
Measuring nociception and optimizing intraoperative antinociceptive medication could potentially improve the conduct of anaesthesia, particularly in older populations.
Does SPI-guided remifentanil administration reduce intraoperative remifentanil consumption in older patients undergoing major abdominal surgery?
RCT (n=80)
Single-blind
Sealed, blinded, and numbered envelope
No
Does SPI-guided remifentanil administration reduce intraoperative remifentanil consumption in older patients undergoing major abdominal surgery?
Absolute Event Rate: 5.6% vs 4.5%
p-value: p=0.14
SPI-guided remifentanil administration did not reduce overall remifentanil consumption or hypotensive events in older patients undergoing major abdominal surgery, though it may allow for more timely opioid adjustment in invasively monitored patients.
SPI guidance does not reduce remifentanil consumption; challenges assumptions of nociception monitoring benefit in elderly abdominal surgery.
The measurement of nociception and the optimisation of intraoperative antinociceptive medication could potentially improve the conduct of anaesthesia, especially in the older population. The Surgical Pleth Index (SPI) is one of the monitoring methods presently used for the detection of nociceptive stimulus. Eighty patients aged 50 years and older who were scheduled to undergo major abdominal surgery were randomised and divided into a study group and a control group. In the study group, the SPI was used to guide the administration of remifentanil during surgery. In the control group, the SPI value was concealed, and remifentanil administration was based on the clinical evaluation of the attending anaesthesiologist. The primary endpoint of this study was intraoperative remifentanil consumption. In addition, we compared the durations of intraoperative hypotension and hypertension. No difference in intraoperative remifentanil consumption (4.5 µg kg − 1 h − 1 vs. 5.6 µg kg − 1 h − 1 , p = 0.14) was found. Furthermore, there was no difference in the proportion of hypotensive time (mean arterial pressure, MAP < 65) (3.7% vs. 1.6%, p = 0.40). However, in the subgroup of patients who underwent operation with invasive blood pressure monitoring, there was less severe hypotension (MAP < 55) (0.3% vs. 0.0%, p = 0.02) and intermediate hypotension (MAP < 65) (10.2% vs. 2.6%, p = 0.07) in the treatment group, even though remifentanil consumption was higher (3.5 µg kg − 1 h − 1 vs. 5.1 µg kg − 1 h − 1 p = 0.03). The use of SPI guidance for the administration of remifentanil during surgery did not help to reduce the remifentanil consumption. However, the results from invasively monitored study group suggest more timely administered opioid when SPI was used.
No takes yet. Share an insight, caveat, or question.
Bergman et al. (2025) conducted an RCT in Major abdominal surgery (n=80). Surgical Pleth Index (SPI)-guided remifentanil administration vs. Standard monitoring and clinical evaluation was evaluated on Intraoperative remifentanil consumption (µg/kg/h) (p=0.14). Surgical Pleth Index-guided administration did not significantly reduce intraoperative remifentanil consumption compared to standard monitoring (5.6 vs 4.5 µg/kg/h, p=0.14).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: